LYKALABSNSELYKA LABS LTD.· PharmaceuticalsMinimalNeutral
Announced Thu, 24 Sept, 2026 · 13:00 IST

Trading window closed from Oct 1 ahead of Q2 results

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.1%Reaction day
₹87.00
prior close
₹88.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.5%+1.6% vs market
Pharmaceuticals peers, median of 172sector-1.0%+1.2% vs sector

On the reaction day the stock moved 1.6 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.1-1.5+1.6-1.0+1.2
Next day
-1.3-1.2-0.1-0.8-0.5
2d
-3.3-2.8-0.5-1.8-1.5
3d
-5.2-1.8-3.4-1.4-3.9
4d
-4.4-2.0-2.3-2.5-1.9
5d
-6.3-3.3-3.0-3.0-3.3
1w
-13.6-2.0-11.5-2.8-10.7
15d
+0.9-3.9+4.9-5.8+6.7
1m
-8.1-10.7+2.7-9.7+1.6
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lyka Labs has closed its trading window from October 1, 2026, until 48 hours after the announcement of unaudited Q2 financial results ending September 30, 2026. The closure applies to designated persons and their immediate relatives, as required under SEBI insider trading rules.

Likely market impact

Routine compliance; signals upcoming Q2 earnings announcement. Designated persons cannot trade until results are out.